Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,726
Feasibility of Aerobic Exercise With Blood Flow Restriction Training in People Living With Type 2 Diabetes
for
Type 2 Diabetes
Location: Fredericton, Guelph
Sponsor: University of New Brunswick
Sex: All
Age: 19 - 64
Code: NCT07196371
Recruiting
Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma
Learning Study: Improving Vision in Adults With Macular Degeneration
for
Macular Degeneration
Location: Waterloo
Sponsor: University of Waterloo
Sex: All
Age: 18+
Code: NCT04762368
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: New York NY, Montreal, Baltimore MD, Ottawa,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase 2, Phase 3, Recruiting
Building Blocks for Child and Family Well-being
for
Parenting Skills, Family Well-being, Family Cohesion
Location: Toronto
Sponsor: York University
Sex: All
Age: 18+
Code: NCT07351630
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Boston MA, Sherbrooke, The Bronx NY, Montreal,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07225569
Phase 2, Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study
Location: Boston MA, Roslyn NY, The Bronx NY, New York NY,
Sponsor: JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
Sex: All
Age: 18+
Code: NCT06455787
Recruiting
Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
for
Hypertension, Hypertrophy
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 19 - 70+
Code: NCT02648009
Phase 1, Recruiting
Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?
for
Acquired Long QT, Ventricular Arrhythmias, Torsades de Pointes,
Location: Toronto, Hamilton
Sponsor: St. Joseph's Healthcare Hamilton
Sex: All
Age: 18+
Code: NCT07374263
Recruiting
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
for
Acute Hypoxemic Respiratory Failure
Location: Toronto
Sponsor: Lorenzo delSorbo
Sex: All
Age: 18+
Code: NCT07334379
Phase 2, Recruiting
Evaluating the Effectiveness of the Nurse Ned Clinic
for
Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Male
Age: 18+
Code: NCT05033301
Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Halifax, Providence RI, Hartford CT, New Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase 3, Recruiting
Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
for
Gynecological Cancers
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Female
Age: 18+
Code: NCT06977126
Phase 1, Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
for
Alzheimer Disease, Agitation
Location: Newton MA, Morehead City NC, Virginia Gardens FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT06937229
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07223047
Phase 1, Phase 2, Recruiting
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
for
Critical Illness
Location: Bowmanville, Oshawa, Ajax, Toronto
Sponsor: Scarborough General Hospital
Sex: All
Age: 16+
Code: NCT07173855
Recruiting
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)